# FDA Inspection 1113169 - Kyowa Hakko Bio Co. Ltd. - November 08, 2019

Source: https://www.keypedia.com/records/fda_inspections/kyowa-hakko-bio-co-ltd/1cff8185-be09-4a42-9b64-38eb6b6d7f02
Source feed: FDA_Inspections

> FDA Inspection 1113169 for Kyowa Hakko Bio Co. Ltd. on November 08, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1113169
- Company Name: Kyowa Hakko Bio Co. Ltd.
- Inspection Date: 2019-11-08
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1026240 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/kyowa-hakko-bio-co-ltd/274c4990-3600-44d7-bc36-7b1584231e09)
- [FDA Inspection 873176 - 2014-03-14](https://www.keypedia.com/records/fda_inspections/kyowa-hakko-bio-co-ltd/95aa0bed-3d66-4df5-9b6b-c2a6cad8cbb1)
- [FDA Inspection 675346 - 2010-07-02](https://www.keypedia.com/records/fda_inspections/kyowa-hakko-bio-co-ltd/2f9fd2c6-f395-453f-847d-e0570cd1daba)

Company: https://www.keypedia.com/companies/kyowa-hakko-bio-co-ltd/09d5ed98-2ceb-4216-8fc1-51327eb2f42a

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c